Frank Seibold

11.9k total citations
112 papers, 4.5k citations indexed

About

Frank Seibold is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Frank Seibold has authored 112 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Genetics, 57 papers in Epidemiology and 31 papers in Immunology. Recurrent topics in Frank Seibold's work include Inflammatory Bowel Disease (68 papers), Microscopic Colitis (41 papers) and Immunodeficiency and Autoimmune Disorders (17 papers). Frank Seibold is often cited by papers focused on Inflammatory Bowel Disease (68 papers), Microscopic Colitis (41 papers) and Immunodeficiency and Autoimmune Disorders (17 papers). Frank Seibold collaborates with scholars based in Switzerland, Germany and United States. Frank Seibold's co-authors include Alain Schoepfer, Michael Trummler, Alex Straumann, Christoph Beglinger, Stephan R. Vavricka, Beatrice Seibold-Schmid, Paul M. Weber, Axel Bouchon, Mirjam Schenk and Christoph Mueller and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.

In The Last Decade

Frank Seibold

108 papers receiving 4.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Frank Seibold	2.4k	2.0k	1.3k	1.2k	675	112	4.5k
Thomas Ochsenkühn	2.8k 1.2×	1.9k 1.0×	1.6k 1.2×	1.5k 1.2×	520 0.8×	99	5.0k
Tariq Ahmad	2.9k 1.2×	1.9k 1.0×	1.4k 1.1×	1.6k 1.4×	687 1.0×	131	5.2k
Alfredo Papa	1.9k 0.8×	1.4k 0.7×	1.4k 1.0×	673 0.6×	493 0.7×	161	3.9k
Yasushi Iwao	1.7k 0.7×	1.5k 0.8×	938 0.7×	939 0.8×	748 1.1×	162	4.3k
Tim Raine	2.8k 1.2×	2.0k 1.0×	1.0k 0.8×	1.4k 1.1×	776 1.1×	97	4.9k
Christian Maaser	2.7k 1.1×	2.1k 1.1×	1.8k 1.4×	1.1k 0.9×	665 1.0×	117	5.6k
Livia Biancone	4.0k 1.7×	2.8k 1.5×	1.9k 1.4×	1.9k 1.6×	1.1k 1.6×	199	6.9k
Takashi Shimoyama	1.5k 0.6×	1.3k 0.6×	1.3k 1.0×	945 0.8×	563 0.8×	136	3.7k
Kim L. Isaacs	2.3k 1.0×	1.5k 0.8×	1.3k 1.0×	654 0.5×	521 0.8×	95	3.9k
Atsushi Sakuraba	2.0k 0.8×	1.6k 0.8×	892 0.7×	1.2k 1.0×	573 0.8×	153	4.2k

Countries citing papers authored by Frank Seibold

Since Specialization

Citations

This map shows the geographic impact of Frank Seibold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Seibold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Seibold more than expected).

Fields of papers citing papers by Frank Seibold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Seibold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Seibold. The network helps show where Frank Seibold may publish in the future.

Co-authorship network of co-authors of Frank Seibold

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Seibold. A scholar is included among the top collaborators of Frank Seibold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Seibold. Frank Seibold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Rogler, Gerhard, Luc Biedermann, Christian Meier, et al.. (2024). Bone health in patients with inflammatory bowel disease. Swiss Medical Weekly. 154(6). 3407–3407. 3 indexed citations

2.

Biedermann, Luc, Michael Doulberis, Philipp Schreiner, et al.. (2024). Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial. Nutrients. 16(23). 4197–4197. 4 indexed citations

3.

Vavricka, Stephan R., Stephan Brand, Patrick Aepli, et al.. (2024). Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency survey. United European Gastroenterology Journal. 13(3). 392–401. 1 indexed citations

4.

Matter, Christoph, Emanuel Burri, Tatiana Galpérine, et al.. (2023). Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice. Swiss Medical Weekly. 153(8). 40100–40100.

5.

Sartoretto, Adrian, et al.. (2023). Transoral Outlet Reduction (TORe) for the Treatment of Weight Regain and Dumping Syndrome after Roux-en-Y Gastric Bypass. Medicina. 59(1). 125–125. 5 indexed citations

6.

Juillerat, Pascal, Luc Biedermann, Pierre Michetti, et al.. (2020). Factors influencing the outcome of vedolizumab treatment: Real‐life data with objective outcome measurements. United European Gastroenterology Journal. 9(3). 398–406. 10 indexed citations

7.

Burri, Emanuel, Michel H. Maillard, Alain Schoepfer, et al.. (2020). Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update. Digestion. 101(Suppl. 1). 2–15. 91 indexed citations

8.

Mottet, Christian, Alain Schoepfer, Pascal Juillerat, et al.. (2016). Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 22(11). 2733–2747. 30 indexed citations

9.

Manser, Christine N., Jan Borovicka, Frank Seibold, et al.. (2016). Risk factors for complications in patients with ulcerative colitis. United European Gastroenterology Journal. 4(2). 281–287. 20 indexed citations

10.

Vavricka, Stephan R., Gerhard Rogler, Muriel Spoerri, et al.. (2015). Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflammatory Bowel Diseases. 21(8). 1794–1800. 188 indexed citations

11.

Greuter, Thomas, Luc Biedermann, Gerhard Rogler, Bernhard Sauter, & Frank Seibold. (2015). Alicaforsen, an antisense inhibitor of ICAM‐1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series. United European Gastroenterology Journal. 4(1). 97–104. 40 indexed citations

12.

Schoepfer, Alain, Stephan R. Vavricka, Janek Binek, et al.. (2009). Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohnʼs disease population. Inflammatory Bowel Diseases. 16(6). 933–938. 22 indexed citations

13.

Schaffer, Thomas, et al.. (2007). Elevated Antibodies against Flagellin support the Concept of Low Grade Mucosal Inflammation in Irritable Bowel Syndrome. Bern Open Repository and Information System (University of Bern). 1 indexed citations

14.

Luckschander, Nicole, Karin Allenspach, Jean A. Hall, et al.. (2006). Perinuclear Antineutrophilic Cytoplasmic Antibody and Response to Treatment in Diarrheic Dogs with Food Responsive Disease or Inflammatory Bowel Disease. Journal of Veterinary Internal Medicine. 20(2). 221–221. 54 indexed citations

15.

Luckschander, Nicole, Karin Allenspach, Jean A. Hall, et al.. (2006). Perinuclear Antineutrophilic Cytoplasmic Antibody and Response to Treatment in Diarrheic Dogs with Food Responsive Disease or Inflammatory Bowel Disease. Journal of Veterinary Internal Medicine. 20(2). 221–227. 58 indexed citations

16.

Seibold, Frank. (2003). Hat die konservative Therapie bei chronisch entzündlichen Darmerkrankungen noch einen Stellenwert?@@@Significance of Medical Therapy in Inflammatory Bowel Disease. Swiss Surgery. 9(3). 127–130. 2 indexed citations

17.

Seibold, Frank, Sydney R. Brandwein, Stephen J. Simpson, Cox Terhorst, & Charles O. Elson. (1998). pANCA Represents a Cross-Reactivity to Enteric Bacterial Antigens. Journal of Clinical Immunology. 18(2). 153–160. 71 indexed citations

18.

Seibold, Frank, et al.. (1997). Pancreatic autoantibodies in Crohn's disease: a family study.. Gut. 40(4). 481–484. 67 indexed citations

19.

Seibold, Frank, P. Weber, Reinhild Klein, P. A. Berg, & K. H. Wiedmann. (1992). Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.. Gut. 33(5). 657–662. 148 indexed citations

20.

Seibold, Frank, P. Weber, H Jenss, & K. H. Wiedmann. (1991). Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease.. Gut. 32(10). 1192–1197. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact